Evidence of cost-effective treatments for depression: a systematic review
- 1 January 2005
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 84 (1) , 1-13
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questionsHealth Economics, 2004
- A pharmacoeconomic evaluation of escitalopram, a new selective serotonin reuptake inhibitorThe European Journal of Health Economics, 2003
- Efficacy and cost-effectiveness of drug and psychological treatments for common mental disorders in general health care in Goa, India: a randomised, controlled trialThe Lancet, 2003
- The 2‐year costs and effects of a public health nursing case management intervention on mood‐disordered single parents on social assistanceJournal of Evaluation in Clinical Practice, 2002
- The London Depression Intervention TrialThe British Journal of Psychiatry, 2000
- Cost Effectiveness of Fluvoxamine in the Treatment of Recurrent Depression in FrancePharmacoEconomics, 1998
- A comparison of the cost-effectiveness of sertraline versus tricyclic antidepressants in primary careJournal of Affective Disorders, 1996
- Modelling the Cost Effectiveness of Antidepressant Treatment in Primary CarePharmacoEconomics, 1995
- The community psychiatric nurse in primary care: an economic analysisJournal of Advanced Nursing, 1995
- Cost Utility of Maintenance Treatment of Recurrent Depression with Sertraline Versus Episodic Treatment with DothiepinPharmacoEconomics, 1994